Improved hmg coa reductase inhibitor extended release...

Details Improved hmg coa reductase inhibitor extended release... Improved hmg coa reductase inhibitor extended release...

A - Human Necessities

61

K

A61K 31/366 (2006.01) A61K 9/22 (2006.01) A61K 9/28 (2006.01) A61K 31/22 (2006.01) A61K 31/351 (2006.01) A61P 3/06 (2006.01) A61K 9/32 (2006.01) A61K 9/36 (2006.01)

Patent

CA 2586240

A controlled release dosage formulation is described which is based on a combination of: (a) a compressed tablet core which contains an alkyl ester of a hydroxy substituted naphthalene derivative, a pharmaceutically acceptable, water swellable polymer and an osmotic agent; and (b) an outer coating layer which completely covers the osmotic core and comprises a pH sensitive coating agent and a water insoluble polymer.

Affiliated with

Also associated with

Rating

Improved hmg coa reductase inhibitor extended release... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved hmg coa reductase inhibitor extended release..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved hmg coa reductase inhibitor extended release... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1414695